EUVIMEDEUVIMED entdecken
Crossref

Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a 5-year retrospective study at a tertiary care centre in Aseer Region, Saudi Arabia

Yasser Alraey, Mohammed Mushabub Assiry, Irfan Ahmad, Safia Obaidur Rab, Abdulaziz Alqahtani, Abdulah A S Bawazeer, Tarig Hussien, Azharuddin Sajid Syed Khaja, Mohd Saleem

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04218-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Yasser Alraey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Anti-Bacterial Agents, Cross Infection. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Between 2019 and 2023, an analysis at the tertiary care centre revealed that 849 out of 1,951 Staphylococcus aureus isolates were methicillin-resistant (Staphylococcus aureus), commonly known as MRSA. According to statistical results, the rate of MRSA infection was markedly higher in patients who received inpatient department care (IPD) at 46.8% than in outpatient department (OPD) at 37.0% (p 0.05). The choice of specimen type affected MRSA detection rates as endotracheal tubes (32.5%, p = 0.004) together with 'Other' samples (e.g.: CSF, bone, bone marrow, bronchial lavage, abdominal aspirate, semen, ETT tip, femoral tip, jugular tip) (54.2%, p = 0.0068) presented higher proportions of infections. Individuals with benign prostatic hyperplasia showed an increased risk of MRSA infection (OR, 1.8; p < 0.0001) along with patients who had chronic lung disease (OR, 1.2; p = 0.048) or recent antibacterial substance use (OR, 2.5; p < 0.0001) while steroid use reduced the risk of MRSA infection (OR, 0.8; p = 0.002). MRSA showed complete resistance against β-lactam antibacterial substances, while all samples remained susceptible to Daptomycin, Linezolid, Nitrofurantoin, and Tigecycline. The sensitivity rate of vancomycin reached 95%, but MRSA displayed significantly reduced susceptibility to fluoroquinolones at 39.3% to 46.3% compared to MSSA, with rates at 81.5% to 85.5%. The percentage of macrolide-resistant bacteria was higher in MRSA, since they showed 28.3%-37.1% susceptibility rates, whereas MSSA had 61.3%-61.8% susceptibility rates. The anti-staphylococcal activity between MRSA and MSSA exceeded 94% for Rifampicin, Teicoplanin, and Fosfomycin. The antibacterial substances, Gentamicin and Tobramycin, showed high sensitivity against MSSA, since their sensitivity reached 92.3% and 91.3%, respectively. Both agents had good sensitivity against MRSA, with rates of 82.4% for gentamicin and 88.9% for tobramycin. Strict antimicrobial stewardship should be implemented as a priority to control the spread of MRSA. Last-line therapies such as vancomycin, daptomycin, and linezolid remain essential treatment options. Regular antimicrobial susceptibility testing is crucial for healthcare professionals to optimize therapy and prevent the development of drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsCross InfectionHumansMaleFemaleTertiary Care CentersSaudi ArabiaRetrospective StudiesMiddle AgedAdultMicrobial Sensitivity TestsAgedYoung AdultAdolescentChildChild, PreschoolRisk Factors

Stichwörter der Autor:innen

Staphylococcus aureusAntimicrobial resistanceHospital-acquired infectionsMRSAMethicillin resistance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Asir Central Hospital, Saudi Ministry of Health, Abha, Saudi Arabia.
  • King Faisal Medical City for South Region, Abha, Saudi Arabia.
  • Department of Obstetrics and Gynaecology, College of Medicine, University of Ha'il, Hail, Saudi Arabia.
  • Department of Pathology, College of Medicine, University of Ha'il, Hail, Saudi Arabia.
  • Department of Pathology, College of Medicine, University of Ha'il, Hail, Saudi Arabia. m.saleem@uoh.edu.sa.

Förderung

  • Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia

Zitieren

APA

Alraey, Y., Assiry, M. M., Ahmad, I., Rab, S. O., Alqahtani, A., Bawazeer, A. A. S., Hussien, T., Syed Khaja, A. S., & Saleem, M. (2025). Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a 5-year retrospective study at a tertiary care centre in Aseer Region, Saudi Arabia. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04218-4

Vancouver

Alraey Y, Assiry MM, Ahmad I, Rab SO, Alqahtani A, Bawazeer AAS, et al. Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a 5-year retrospective study at a tertiary care centre in Aseer Region, Saudi Arabia. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04218-4

BibTeX
@article{Alraey2025,
  author = {Alraey, Yasser and Assiry, Mohammed Mushabub and Ahmad, Irfan and Rab, Safia Obaidur and Alqahtani, Abdulaziz and Bawazeer, Abdulah A S and Hussien, Tarig and Syed Khaja, Azharuddin Sajid and Saleem, Mohd},
  title = {Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a 5-year retrospective study at a tertiary care centre in Aseer Region, Saudi Arabia},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04218-4}
}
Kostenlos starten →